Terms: = Testicular cancer AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Prognosis
6 results:
1. Male breast cancer: an update.
Fox S; Speirs V; Shaaban AM
Virchows Arch; 2022 Jan; 480(1):85-93. PubMed ID: 34458944
[TBL] [Abstract] [Full Text] [Related]
2. Clinical relevance of her-2/neu overexpression in patients with testicular nonseminomatous germ cell tumor.
Ghavamnasiri MR; Saeedi Saedi H; Shahid Sales S; Ghafarzadegan K
Urol J; 2010; 7(1):26-9. PubMed ID: 20209452
[TBL] [Abstract] [Full Text] [Related]
3. CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients.
Salnikov AV; Gladkich J; Moldenhauer G; Volm M; Mattern J; Herr I
Int J Cancer; 2010 Feb; 126(4):950-8. PubMed ID: 19676044
[TBL] [Abstract] [Full Text] [Related]
4. Association between sarcoidosis and testicular carcinoma: a diagnostic pitfall.
Paparel P; Devonec M; Perrin P; Ruffion A; Decaussin-Petrucci M; Akin O; Sheinfeld J; Guillonneau B
Sarcoidosis Vasc Diffuse Lung Dis; 2007 Sep; 24(2):95-101. PubMed ID: 18496978
[TBL] [Abstract] [Full Text] [Related]
5. Recent advances in conventional-dose salvage chemotherapy in patients with cisplatin-resistant or refractory testicular germ cell tumors.
Farmakis D; Pectasides M; Pectasides D
Eur Urol; 2005 Sep; 48(3):400-7. PubMed ID: 15964136
[TBL] [Abstract] [Full Text] [Related]
6. Expression of her-2/neu in testicular tumors.
Mandoky L; Geczi L; Bodrogi I; Toth J; Bak M
Anticancer Res; 2003; 23(4):3447-51. PubMed ID: 12926088
[TBL] [Abstract] [Full Text] [Related]
